We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

13 hedge funds and large institutions have $227K invested in Tonix Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.04% more ownership

Funds ownership: 0% → 0.05% (+0.04%)

46% less funds holding

Funds holding: 24 → 13 (-11)

79% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 14

90% less capital invested

Capital invested by funds: $2.24M → $227K (-$2.01M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
13
Holders Change
-11
Holders Change %
-45.83%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
7
Reduced
–
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Prudential Financial
Prudential Financial
New Jersey
+$424K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$215K
3
HF
HRT Financial
New York
+$97.6K
4
Jane Street
Jane Street
New York
+$48.1K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$39.9K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$911K
2
Marshall Wace
Marshall Wace
United Kingdom
-$309K
3
AC
Armistice Capital
New York
-$91K
4
Renaissance Technologies
Renaissance Technologies
New York
-$23K
5
Millennium Management
Millennium Management
New York
-$21.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
1
Prudential Financial
New Jersey
$68.1K +$424K +935 +2,226%
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$43.6K – – –
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$39K +$215K +473 +450%
RA
4
Rosalind Advisors
Ontario, Canada
$19.6K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$17.7K +$39.9K +88 +53%
HF
6
HRT Financial
New York
$15K +$97.6K +215 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$11.5K +$18.2K +40 +32%
Jane Street
8
Jane Street
New York
$7.64K +$48.1K +106 +2,650%
TRCT
9
Tower Research Capital (TRC)
New York
$3.51K +$17.7K +39 +355%
BlackRock
10
BlackRock
New York
$885 – – –
Qube Research & Technologies (QRT)
11
Qube Research & Technologies (QRT)
United Kingdom
$210 +$1.36K +3 New
Morgan Stanley
12
Morgan Stanley
New York
$176 +$454 +1 +50%
UBS Group
13
UBS Group
Switzerland
$35 +$454 +1 New
Bank of America
14
Bank of America
North Carolina
$19 – – –
BNP Paribas Financial Markets
15
BNP Paribas Financial Markets
France
$7 – – –
JP Morgan Chase
16
JP Morgan Chase
New York
$6 – – –
NL
17
NVWM LLC
Pennsylvania
$3 – – –
AWM
18
Activest Wealth Management
Florida
$1 – – –
AF
19
Allworth Financial
California
$1 – – –
CTC
20
Central Trust Company
Missouri
$1 – – –
GRP
21
Global Retirement Partners
California
$1 – – –
PCMC
22
Planning Capital Management Corporation
Pennsylvania
$1 – – –
TLCM
23
Twin Lakes Capital Management
California
$1 – – –
SM
24
Sabby Management
Florida
– -$911K -1,530 Closed
Marshall Wace
25
Marshall Wace
United Kingdom
– -$309K -509 Closed
1
2

TNXP Hedge Fund Activity: Q2 2024 in Review

13 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2024, worth a combined $227K — down 90% from $2.24M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TNXP and 3 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 7 added.

The largest buyer was Prudential Financial, adding an estimated $424K. The largest seller was Sabby Management, exiting entirely with an estimated $911K sold.

  • 13 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2024, down from 24 in Q1 2024.
  • Funds reported $227K of Tonix Pharmaceuticals stock for Q2 2024, down 90% quarter-over-quarter.
  • 3 funds opened new Tonix Pharmaceuticals positions in Q2 2024 and 14 closed out, a net change of -11 holders.
  • The largest Tonix Pharmaceuticals buyer in Q2 2024 was Prudential Financial, an estimated $424K added.
  • The largest Tonix Pharmaceuticals seller in Q2 2024 was Sabby Management, an estimated $911K sold.

Based on aggregated 13F filings for Q2 2024.